Company Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-03-18 pm EDT 5-day change 1st Jan Change
92.85 USD +0.58% Intraday chart for Edwards Lifesciences Corporation +2.22% +21.77%

Business Summary

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:

- hemodynamic monitoring systems (65.4%);

- heart valves and surgery products (18.7%);

- other (15.9%): balloon catheters, artificial implants, etc.

Net sales are distributed geographically as follows: the United States (58.2%), Europe (21.8%), Japan (8.8%) and other (11.2%).

Number of employees: 19,800

Sales per Business

USD in Million2022Weight2023Weight Delta
Transcatheter Mitral and Tricuspid Therapies
64.6 %
3,518 65.4 % 116 2.2 % 3,880 64.6 % +3,241.77%
Surgical Heart Valve Therapy
16.6 %
893 16.6 % 999 16.6 % +11.89%
Critical Care
15.5 %
855 15.9 % 928 15.5 % +8.55%
Transcatheter Mitral and Tricuspid Therapies
3.3 %
3,518 65.4 % 116 2.2 % 198 3.3 % +70.20%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
58.4 %
3,133 58.2 % 3,509 58.4 % +12.01%
Europe
22.2 %
1,175 21.8 % 1,335 22.2 % +13.59%
Rest of World
11.8 %
601 11.2 % 709 11.8 % +17.92%
Japan
7.5 %
474 8.8 % 452 7.5 % -4.48%

Managers

Managers TitleAgeSince
Chief Executive Officer 57 14-12-31
Chairman 71 99-12-31
Director of Finance/CFO 57 13-12-31
Chief Tech/Sci/R&D Officer - 19-01-31
Investor Relations Contact - -
General Counsel 46 -
Corporate Officer/Principal 65 17-06-30
Corporate Officer/Principal - 11-06-30
Corporate Officer/Principal 62 94-12-31
General Counsel 59 14-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 63 16-07-04
Director/Board Member 67 14-11-12
Director/Board Member 72 16-03-15
Chairman 71 99-12-31
Director/Board Member 66 20-07-12
Director/Board Member 60 15-02-09
Director/Board Member 75 15-10-21
Director/Board Member 58 20-05-06
Chief Executive Officer 57 14-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 650,700,000 596,068,856 ( 91.60 %) 49,400,000 ( 7.592 %) 91.60 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
8.708 %
52,363,400 8.708 % 4 444 M $
BlackRock Advisors LLC
6.436 %
38,698,038 6.436 % 3 284 M $
26,955,650 4.483 % 2 288 M $
AllianceBernstein LP
3.402 %
20,457,405 3.402 % 1 736 M $
Brown Investment Advisory & Trust Co.
3.024 %
18,181,420 3.024 % 1 543 M $
BNY Mellon Investment Adviser, Inc.
2.882 %
17,328,617 2.882 % 1 471 M $
Wellington Management Co. LLP
2.799 %
16,827,510 2.799 % 1 428 M $
Geode Capital Management LLC
2.140 %
12,868,144 2.140 % 1 092 M $
BlackRock Life Ltd.
2.061 %
12,393,994 2.061 % 1 052 M $
Capital Research & Management Co. (International Investors)
1.504 %
9,041,560 1.504 % 767 M $

Company contact information

Edwards Lifesciences Corp.

1 Edwards Way

92614, Irvine

+949 250 2500

http://www.edwards.com
address Edwards Lifesciences Corporation(EW)

Group companies

NameCategory and Sector
Medical Specialties
Edwards Lifesciences Technology SARL
Medical Specialties
Medical Specialties
  1. Stock
  2. Equities
  3. Stock Edwards Lifesciences Corporation - Nyse
  4. Company Edwards Lifesciences Corporation